Evidence map›Paper›PMID 19272320›Full record

ArticleExperimental cell research2009

A-type nuclear lamins act as transcriptional repressors when targeted to promoters.

Damian C Lee, K Linnea Welton, Erica D Smith, Brian K Kennedy

Open access · greenAbstract read
In one paragraph

Article in Experimental cell research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Aging and disease · 2019
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mechanical regulation of nuclear structure and function.Annual review of biomedical engineering · 2012
    Review
  19. Review
  20. Gene positioning and expression.Current opinion in cell biology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Damian C LeeDepartment of Biochemistry, University of Washington, Seattle, WA 98195, USA.
K Linnea Welton
Erica D Smith
Brian K Kennedy
University of Washington · US

Funding

Nuclear Lamin Functions and Human DiseaseR01AG024287 · NIA · UNIVERSITY OF WASHINGTON · PI KENNEDY, BRIAN K · 2004 to 2013
$3.0M
NIA NIH HHS R01 AG024287NIA NIH HHS R01AG024287
6 · The paper itself

Abstract

Regions of heterochromatin are often found at the periphery of the mammalian nucleus, juxtaposed to the nuclear lamina. Genes in these regions are likely maintained in a transcriptionally silent state, although other locations at the nuclear periphery associated with nuclear pores are sites of active transcription. As primary components of the nuclear lamina, A- and B-type nuclear lamins are intermediate filament proteins that interact with DNA, histones and known transcriptional repressors, leading to speculation that they may promote establishment of repressive domains. However, no direct evidence of a role for nuclear lamins in transcriptional repression has been reported. Here we find that human lamin A, when expressed in yeast and cultured human cells as a fusion protein to the Gal4 DNA-binding domain (DBD), can mediate robust transcriptional repression of promoters with Gal4 binding sites. Full repression by lamin A requires both the coiled-coil rod domain and the C-terminal tail domain. In human cells, other intermediate filament proteins such as lamin B and vimentin are unable to confer robust repression as Gal4-DBD fusions, indicating that this property is specific to A-type nuclear lamins. These findings indicate that A-type lamins can promote transcriptional repression when in proximity of a promoter.

Indexed as

Promoter Regions, GeneticTranscription, GeneticCell LineCell NucleusGene Expression RegulationGenes, ReporterHumansLamin Type ARecombinant Fusion ProteinsRepressor ProteinsTwo-Hybrid System TechniquesVimentinLamin Type ARecombinant Fusion ProteinsRepressor ProteinsVimentin

Identifiers

PMID19272320
PMCPMC2746445
OpenAlexW1992713810

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.